Lincoln Pharmaceuticals Ltd. (LINCOLN)
Market Open
15 Oct, 10:00 AM
XNSE ₹
556. 20
+13.3
+2.4498%
₹
- Market Cap
- P/E Ratio
6% Div Yield
73,258 Volume
- Eps
₹ 542.9
Previous Close Want to track LINCOLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lincoln Pharmaceuticals Ltd. (LINCOLN) Statistics
Valuation metrics
Market Cap -
Enterprise value 11.18B
Trailing P/E (ttm) 11.59
Forward P/E -
PEG ratio 0.99
Price/Sales (ttm) 1.56
Price/Book (mrq) 1.48
Enterprise Value/Revenue 1.56
Enterprise Value/EBITDA 8.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 28.77K
Average volume (90 days) 45.99K
Price summary
52-Week low 440
52-Week high 770
Beta -
50-Day moving average 602.26
200-Day moving average 616.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.8
Trailing annual dividend yield 0.0032%
5-Year annual dividend yield -
Payout ratio 0
Dividend Date 30 Oct 2025
Ex-Dividend Date 12 Sep 2025
Last split factor 2:10
Last split Date 19 Mar 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 358.71
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 48.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 120.42
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.25%
Book value per share (mrq) 378.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
